TipRanks
30 days ago
TipRanks
30 days ago
TipRanks
30 days ago
Nasdaq News: Stocks
30 days ago
TipRanks
30 days ago
TipRanks
30 days ago
TipRanks
30 days ago
Fool.com Headlines
30 days ago
TipRanks
30 days ago
TipRanks
30 days ago
PR Newswire
30 days ago
TipRanks
30 days ago
TipRanks
30 days ago
TipRanks
30 days ago
TipRanks
30 days ago

AbbVie's New Phase 1 ABBV-859 Trial: Early Pipeline Signal for Long-Term Investors

TipRanks
30 days ago

AbbVie's ABBV-722 Clears Key Safety Hurdle in Contraceptive Interaction Study

TipRanks
30 days ago

Shionogi's Redasemtide Stroke Trial Completion: What Investors Should Watch Next

TipRanks
30 days ago

In The Middle Of A War, The Trump Administration Has Cut National Security Staffing In Half

Techdirt
30 days ago

Bayer Halts Mirena Phase 3 Trial in Uterine Health: What It Means for BAYRY Investors

TipRanks
30 days ago

CVRx's REBALANCE Registry Update: What the Termination Means for Barostim Investors

TipRanks
30 days ago

Climb Bio's Budoprutug Trial Completion Sets Stage for Next Investor Catalyst

TipRanks
30 days ago

Chugai's SPYK04 Trial Completion: What It Means for CHGCF Investors

TipRanks
30 days ago

Lilly's Retatrutide Trial Reaches Completion, Setting Up Next Catalyst in Obesity and Heart Disease

TipRanks
30 days ago

GSK Advances mRNA RSV Vaccine Program With Completed Phase 1 Study

TipRanks
30 days ago

Nvidia (NVDA) Could Backstop $250 Billion for OpenAI. Where Does That Leave Microsoft (MSFT)?

Insider Monkey
30 days ago

Lilly's Retatrutide Trial Completion Signals Next Wave in Diabetes and Obesity Drugs

TipRanks
30 days ago

The Ultimate Bull Run for AMD, Broadcom, and Arm May Be Closer Than You Think

24/7 Wall St.
30 days ago

A New Crypto Index Just Launched. Here's Why That's Bullish for Ethereum, Solana, and Hyperliquid.

Fool.com Headlines
30 days ago

How a Self-Published Vampire Romantasy Novel Took Over BookTok and Made Its Author a No.1 Bestseller

Entrepreneur
30 days ago